Skip to Main Content

Paper Details

Nivolumab plus ipilimumab for soft tissue sarcoma: a single institution retrospective review.
Immunotherapy
8
2020
Author NameAffiliation
Nam BuiStanford University School of Medicine
  • 1 - 1

Datasets

Release 1.2